July 27, 2023 /Medtech Outlook/ – “Our mission is to develop and commercialize novel products to intraoperatively ablate surgical margins post-excision for treating early-stage breast cancer. Developed by a team of surgeons and graduate students at Northwestern University, our SIRAT™ device aims to leverage RFA to reduce reoperations and local recurrence in breast cancer treatment,” says Richard Stark, CEO of Innoblative Designs.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.